Voyager Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Voyager Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2014 to Q2 2024.
  • Voyager Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$10.1M, a 54.3% increase year-over-year.
  • Voyager Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $9.02M, a 90.6% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $132M.
  • Voyager Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.4M, a 34.8% increase from 2021.
  • Voyager Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$71.2M, a 294% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.02M -$10.1M +$12.1M +54.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$3.04M -$11.3M -$135M -109% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-06
Q4 2023 $132M $56.4M +$80M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $52.3M -$25.9M -$43.5M -247% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $95.8M -$22.2M -$3.12M -16.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $99M $124M +$145M Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-06
Q4 2022 -$46.4M -$23.6M -$29.3M -514% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$17.1M $17.6M +$42.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$59.8M -$19.1M +$11M +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$70.9M -$21.3M +$330K +1.52% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2021 -$71.2M $5.71M +$21.6M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$92.8M -$25.1M -$111M -129% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $17.9M -$30.1M -$21.4M -247% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 $39.4M -$21.6M +$2.61M +10.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 $36.7M -$15.9M -$3.35M -26.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $40.1M $85.6M +$101M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$60.5M -$8.68M -$19.8M -178% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$40.7M -$24.3M +$2.91M +10.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$43.6M -$12.6M +$9.96M +44.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-03
Q3 2019 -$53.6M -$15M +$5.28M +26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$58.8M $11.2M +$36.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$95.5M -$27.2M -$7.24M -36.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$88.3M -$22.5M -$10.7M -90.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$77.6M -$20.3M +$3.06M +13.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$80.6M -$25.5M -$6.67M -35.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$74M -$19.9M -$3.28M -19.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 -$70.7M -$11.8M +$2.85M +19.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$73.5M -$23.3M -$14.4M -160% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$59.2M -$18.9M -$9.54M -102% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$49.7M -$16.6M -$9.46M -132% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
Q4 2016 -$40.2M -$14.7M -$7.39M -101% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 -$32.8M -$9M -$5.08M -130% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$27.7M -$9.34M -$5.44M -140% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$22.3M -$7.19M +$7.39M +50.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$29.7M -$7.28M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$3.92M +$88K +2.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$3.9M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$14.6M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 -$4.01M Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.